Showing 1,658 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Pharmaceutical industry

Fair Pricing Coalition Disappointed by the High Price of New Janssen Hepatitis C Drug Olysio (simeprevir)

Editor's pick
Fair Pricing Coalition
29 November 2013
Activism & civil society

Ukraininan HIV patients’ organisation is first-ever NGO to get PR award

Editor's pick
Ukrainian Community Advosory Board
28 November 2013
Hepatitis C symptoms & diagnosis

AASLD 2013: Aspirin and Cenicriviroc May Help Reduce Liver Fibrosis

Editor's pick
HIVandhepatitis.com
28 November 2013
New & experimental hepatitis C treatment

Gilead responds over India patent pressure on HCV drug

Editor's pick
PharmaTimes
27 November 2013
New & experimental hepatitis C treatment

Meeting report of the International multi-stakeholders meeting on the compassionate use of HCV treatment

Editor's pick
EATG
26 November 2013
New & experimental hepatitis C treatment

European Medicines Agency advises on compassionate use of daclatasvir

Editor's pick
European Medicines Agency
26 November 2013
Access to healthcare

Indian health activists move to prevent Gilead’s drug patent

Editor's pick
Financial Times
26 November 2013
New & experimental hepatitis C treatment

FDA approves new treatment for hepatitis C virus

Editor's pick
US FDA
23 November 2013
New & experimental hepatitis C treatment

European Medicines Agency recommends approval of sofosbuvir for the treatment of chronic hepatitis C

Editor's pick
European Medicines Agency
22 November 2013
Treatment guidelines

BHIVA Autumn Conference: Presentations now available online

Editor's pick
British HIV Association
19 November 2013
New & experimental hepatitis C treatment

AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy

Editor's pick
AbbVie press release
18 November 2013
Hepatitis & HIV

Training manual for treatment advocates: Hepatitis C virus and coinfection with HIV

Editor's pick
TAG
18 November 2013
Hepatitis C treatment

Primary Care Option for Hepatitis C Treatment Cost-Effective

Editor's pick
Medscape (requires registration)
15 November 2013
Hepatitis C treatment

Costs for Hepatitis C Treatment Skyrocket

Editor's pick
Medscape (requires registration)
14 November 2013
Organ transplants

Congress Votes To End The Outdated Ban On HIV Organ Transplants And Research

Editor's pick
ThinkProgress
13 November 2013
New & experimental hepatitis C treatment

How Much? A Battle Over The Cost Of The New Hepatitis C Drugs

Editor's pick
Pharmalot
12 November 2013
New & experimental hepatitis C treatment

Hepatitis C, a Silent Killer, Meets Its Match

Editor's pick
New York Times
5 November 2013
New & experimental hepatitis C treatment

Gilead Announces Phase 2 Results for Sofosbuvir-Based Regimens in Hepatitis C Patients Before and After Liver Transplantation

Editor's pick
Gilead press release
3 November 2013
New & experimental hepatitis C treatment

Gilead Announces New Sustained Viral Response Data for Sofosbuvir-Based Regimens in Genotype 3-Infected Hepatitis C Patients

Editor's pick
Gilead press release
3 November 2013
New & experimental hepatitis C treatment

Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising Phase II data

Editor's pick
Boehringer Ingelheim
3 November 2013
New & experimental hepatitis C treatment

High cure rates seen with Merck oral hepatitis drugs - study

Editor's pick
Reuters
3 November 2013
Hepatitis C treatment

Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant

Editor's pick
Eurekalert Medicine & Health
1 November 2013
Hepatitis C treatment

Studies: Current hepatitis C treatments can't be used by more than half of patients; others lose opportunity for treatment

Editor's pick
Eurekalert Medicine & Health
1 November 2013
New & experimental hepatitis C treatment

Idenix provides HCV pipeline update

Editor's pick
Idenix press release
1 November 2013